XML 27 R17.htm IDEA: XBRL DOCUMENT
v3.19.2

Stock Compensation Plans | 9 Months Ended
--- | ---
Jun. 30, 2019
Share-based Payment Arrangement, Noncash Expense [Abstract] |
Stock Compensation Plans | STOCK COMPENSATION PLANS Under the Company’s 2003 Stock Option Plan, the Company was able to grant options for up to 300,000 shares of common stock to employees, officers, directors and directors emeriti. Under the Company's 2014 Equity Incentive Plan, the Company is able to grant options and awards of restricted stock (with or without performance measures) for up to 352,366 shares of common stock to employees, officers, directors and directors emeriti. Shares issued may be purchased in the open market or may be issued from authorized and unissued shares. The exercise price of each option equals the fair market value of the Company’s common stock on the date of grant. Generally, options and restricted stock vest in 20% annual installments on each of the five anniversaries from the date of the grant, and options generally have a maximum contractual term of ten years from the date of grant. At June 30, 2019, there were 75,316 shares of common stock available which may be awarded as options or restricted stock pursuant to future grant under the 2014 Equity Incentive Plan. At both June 30, 2019 and 2018, there were no unvested restricted stock awards. There were no restricted stock grants awarded during the nine months ended June 30, 2019 or 2018. Stock option activity for the nine months ended June 30, 2019 and 2018 is summarized as follows:
| Nine Months Ended June 30, 2019 |  | Nine Months Ended June 30, 2018
| Number of Shares |  |  | Weighted Average Exercise Price |  |  | Number of Shares |  |  | Weighted Average Exercise Price |
Options outstanding, beginning of period | 380,820 |  |  | $ | 16.03 |  |  | 380,120 |  |  | $ | 13.23 |
Exercised | (37,756 | ) |  | 9.00 |  |  | (34,850 | ) |  | 8.39 |
Forfeited | (3,900 | ) |  | 18.63 |  |  | (5,150 | ) |  | 13.39 |
Options outstanding, end of period | 339,164 |  |  | $ | 16.79 |  |  | 340,120 |  |  | $ | 13.73 |
The aggregate intrinsic value of options exercised during the nine months ended June 30, 2019 and 2018 was $751,000 and $741,000, respectively. At June 30, 2019, there were 155,750 unvested options with an aggregate grant date fair value of $485,000, all of which the Company assumes will vest. The aggregate intrinsic value of unvested options at June 30, 2019 was $1.09 million. There were 37,300 options with an aggregate grant date fair value of $88,000 that vested during the nine months ended June 30, 2019. At June 30, 2018, there were 183,150 unvested options with an aggregate grant date fair value of $454,000. There were 43,900 options with an aggregate grant date fair value of $104,000 that vested during the nine months ended June 30, 2018.
Additional information regarding options outstanding at June 30, 2019 is as follows:
|  | Options Outstanding |  | Options Exercisable
Range of Exercise Prices ($) |  | Number |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Life (Years) |  | Number |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Life (Years)
$ 4.01 - 4.55 |  | 2,500 |  |  | $ | 4.33 |  |  | 1.2 |  | 2,500 |  |  | $ | 4.33 |  |  | 1.2
5.86 - 6.00 |  | 19,850 |  |  | 5.97 |  |  | 3.3 |  | 19,850 |  |  | 5.97 |  |  | 3.3
9.00 |  | 52,775 |  |  | 9.00 |  |  | 4.3 |  | 52,775 |  |  | 9.00 |  |  | 4.3
10.26 - 10.71 |  | 113,189 |  |  | 10.58 |  |  | 5.8 |  | 79,989 |  |  | 10.55 |  |  | 5.7
15.67 |  | 48,800 |  |  | 15.67 |  |  | 7.3 |  | 17,000 |  |  | 15.67 |  |  | 7.3
29.69 |  | 56,100 |  |  | 29.69 |  |  | 8.3 |  | 11,300 |  |  | 29.69 |  |  | 8.3
31.80 |  | 45,950 |  |  | 31.80 |  |  | 9.3 |  | — |  |  | N/A |  |  | N/A
|  | 339,164 |  |  | $ | 16.79 |  |  | 6.5 |  | 183,414 |  |  | $ | 11.18 |  |  | 5.3
The aggregate intrinsic value of options outstanding at June 30, 2019 and 2018 was $4.53 million and $8.03 million, respectively. As of June 30, 2019, unrecognized compensation cost related to non-vested stock options was $401,000, which is expected to be recognized over a weighted average life of 2.14 years.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration